Source author record

Stuart Pomerantz

Stuart Pomerantz appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

1works
2topics
2close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

1 published item(s)

preprint2022arXiv

Improving Trustworthiness of AI Disease Severity Rating in Medical Imaging with Ordinal Conformal Prediction Sets

The regulatory approval and broad clinical deployment of medical AI have been hampered by the perception that deep learning models fail in unpredictable and possibly catastrophic ways. A lack of statistically rigorous uncertainty quantification is a significant factor undermining trust in AI results. Recent developments in distribution-free uncertainty quantification present practical solutions for these issues by providing reliability guarantees for black-box models on arbitrary data distributions as formally valid finite-sample prediction intervals. Our work applies these new uncertainty quantification methods -- specifically conformal prediction -- to a deep-learning model for grading the severity of spinal stenosis in lumbar spine MRI. We demonstrate a technique for forming ordinal prediction sets that are guaranteed to contain the correct stenosis severity within a user-defined probability (confidence interval). On a dataset of 409 MRI exams processed by the deep-learning model, the conformal method provides tight coverage with small prediction set sizes. Furthermore, we explore the potential clinical applicability of flagging cases with high uncertainty predictions (large prediction sets) by quantifying an increase in the prevalence of significant imaging abnormalities (e.g. motion artifacts, metallic artifacts, and tumors) that could degrade confidence in predictive performance when compared to a random sample of cases.